Kentucky Retirement Systems Insurance Trust Fund lifted its holdings in shares of Danaher Co. (NYSE:DHR – Free Report) by 11.6% in the fourth quarter, Holdings Channel.com reports. The institutional investor owned 21,233 shares of the conglomerate’s stock after purchasing an additional 2,202 shares during the quarter. Kentucky Retirement Systems Insurance Trust Fund’s holdings in Danaher were worth $4,874,000 as of its most recent filing with the Securities & Exchange Commission.
Several other institutional investors and hedge funds have also recently bought and sold shares of the business. Heck Capital Advisors LLC acquired a new position in shares of Danaher during the fourth quarter valued at $27,000. Decker Retirement Planning Inc. acquired a new position in Danaher during the 4th quarter valued at about $31,000. Golden State Wealth Management LLC bought a new position in Danaher in the 4th quarter worth about $31,000. Strategic Financial Concepts LLC bought a new stake in shares of Danaher during the fourth quarter valued at approximately $31,000. Finally, Pineridge Advisors LLC boosted its position in shares of Danaher by 63.3% during the fourth quarter. Pineridge Advisors LLC now owns 147 shares of the conglomerate’s stock worth $34,000 after buying an additional 57 shares during the period. Institutional investors and hedge funds own 79.05% of the company’s stock.
Insiders Place Their Bets
In other news, SVP Brian W. Ellis sold 5,700 shares of the stock in a transaction that occurred on Thursday, January 30th. The stock was sold at an average price of $224.13, for a total transaction of $1,277,541.00. Following the completion of the transaction, the senior vice president now directly owns 20,230 shares of the company’s stock, valued at approximately $4,534,149.90. This represents a 21.98 % decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. 11.10% of the stock is currently owned by corporate insiders.
Wall Street Analyst Weigh In
Check Out Our Latest Report on Danaher
Danaher Stock Performance
NYSE DHR opened at $206.66 on Tuesday. Danaher Co. has a fifty-two week low of $196.80 and a fifty-two week high of $281.70. The firm has a market capitalization of $149.26 billion, a P/E ratio of 39.14, a price-to-earnings-growth ratio of 2.68 and a beta of 0.83. The stock’s fifty day moving average is $229.53 and its two-hundred day moving average is $249.13. The company has a debt-to-equity ratio of 0.31, a quick ratio of 1.05 and a current ratio of 1.40.
Danaher (NYSE:DHR – Get Free Report) last released its earnings results on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share for the quarter, meeting the consensus estimate of $2.14. Danaher had a return on equity of 10.82% and a net margin of 16.33%. During the same period in the prior year, the company posted $2.09 earnings per share. On average, research analysts anticipate that Danaher Co. will post 7.67 earnings per share for the current year.
Danaher Dividend Announcement
The company also recently announced a quarterly dividend, which was paid on Friday, January 31st. Investors of record on Friday, December 27th were given a $0.27 dividend. The ex-dividend date of this dividend was Friday, December 27th. This represents a $1.08 dividend on an annualized basis and a dividend yield of 0.52%. Danaher’s dividend payout ratio (DPR) is presently 20.45%.
About Danaher
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.
Featured Stories
- Five stocks we like better than Danaher
- 3 Must-Buy Warren Buffett Stocks for Volatile Times
- Beyond DeepSeek: 4 Chinese ETFs for AI & Tech Exposure
- How to Invest in Tech Stocks and Top Tech Stocks to Consider
- Airbnb’s Earnings: Sky High Results, Grounded Guidance?
- The Risks of Owning Bonds
- Kyndryl Soars on AI, Cybersecurity Growth—What’s Next?
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHR – Free Report).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.